Oncology

Research Line

INTRODUCTION

Content will be added shortly.

Sl No. Title Authors Journal Name Publication Year
1 High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS Cancer Med 2016
2 β3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Exp Cell Res 2016
3 Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Data Brief 2016
4 Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer Korlimarla A, Prabhu JS, Remacle J, Rajarajan S, Raja U, C E A, Srinath BS, Manjunath S, K S G, Correa M, M S N P, Sridhar TS PLoS One 2016
5 A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS J Cancer 2014
6 Separate quality-control measures are necessary for estimation of RNA and methylated DNA from formalin-fixed, paraffin-embedded specimens by quantitative PCR Korlimarla A, Prabhu JS, Anupama CE, Remacle J, Wahi K, Sridhar TS J Mol Diagn 2014
7 Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS Korlimarla A, Bhandary L, Prabhu JS, Shankar H, Sankaranarayanan H, Kumar P, Remacle J, Natarajan D, Sridhar TS Cell Mol Biol Lett 2013
8 The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women Prabhu JS, Wahi K, Korlimarla A, Correa M, Manjunath S, Raman N, Srinath BS, Sridhar TS Tumour Biology 2012
9 Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype? Manjunath S, Prabhu JS, Kaluve R, Correa M, Sridhar TS Indian J Surg Oncol 2011
10 A bibliometric analysis of published non-communicable disease research in India Mony P, Srinivasan K Indian J Med Res 2011
11 Prospective study of one million deaths in India: rationale, design, and validation results Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, Peto R; RGI-CGHR Prospective Study Collaborators PLoS Med 2006